Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Cyclically Adjusted FCF per Share: ¥1.28 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603882 Guangzhou Kingmed Diagnostics Group Co Ltd SHSE:603882
75 GF Score
Price ¥28.97
GF Value ¥28.10
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Guangzhou Kingmed Diagnostics Group Co Cyclically Adjusted FCF per Share?

Guangzhou Kingmed Diagnostics Group Co SHSE:603882 +3.35% 75 Cyclically Adjusted FCF per Share is ¥1.28 as of Mar. 2026. GuruFocus rates SHSE:603882 with a GF Score™ of 75/100 and a GF Value™ of ¥28.10 (Fairly Valued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Guangzhou Kingmed Diagnostics Group Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥-0.136. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥1.28 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Guangzhou Kingmed Diagnostics Group Co's average Cyclically Adjusted FCF Growth Rate was 4.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-08), Guangzhou Kingmed Diagnostics Group Co's current stock price is ¥28.97. Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥1.28. Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF of today is 22.63.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Guangzhou Kingmed Diagnostics Group Co was 26.09. The lowest was 17.31. And the median was 23.19.


Guangzhou Kingmed Diagnostics Group Co  (SHSE:603882) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=28.97/1.28
=22.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Guangzhou Kingmed Diagnostics Group Co was 26.09. The lowest was 17.31. And the median was 23.19.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Guangzhou Kingmed Diagnostics Group Co Cyclically Adjusted FCF per Share Related Terms


Guangzhou Kingmed Diagnostics Group Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Kingmed Diagnostics Group Co Cyclically Adjusted FCF per Share Chart

Guangzhou Kingmed Diagnostics Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.33

Guangzhou Kingmed Diagnostics Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.23 1.25 1.27 1.33 1.28

SHSE:603882 vs TMO, DHR, IDXX: Cyclically Adjusted FCF per Share Comparison

For the Diagnostics & Research subindustry, Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Kingmed Diagnostics Group Co Cyclically Adjusted Price-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:603882
75GF Score
Guangzhou Kingmed Diagnostics Group Co Ltd SHSE:603882
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangzhou Kingmed Diagnostics Group Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guangzhou Kingmed Diagnostics Group Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.136/116.3033*116.3033
=-0.136

Current CPI (Mar. 2026) = 116.3033.

Guangzhou Kingmed Diagnostics Group Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201512 0.000 100.600 0.000
201609 0.000 102.400 0.000
201612 0.000 102.600 0.000
201703 -0.312 103.200 -0.352
201706 -0.084 103.100 -0.095
201709 0.022 104.100 0.025
201712 0.085 104.500 0.095
201803 -0.232 105.300 -0.256
201806 0.153 104.900 0.170
201809 0.116 106.600 0.127
201812 0.374 106.500 0.408
201903 -0.142 107.700 -0.153
201906 0.209 107.700 0.226
201909 0.265 109.800 0.281
201912 0.511 111.200 0.534
202003 -0.454 112.300 -0.470
202006 0.552 110.400 0.582
202009 1.182 111.700 1.231
202012 0.873 111.500 0.911
202103 -0.030 112.662 -0.031
202106 0.517 111.769 0.538
202109 0.332 112.215 0.344
202112 1.630 113.108 1.676
202203 -0.281 114.335 -0.286
202206 1.222 114.558 1.241
202209 0.580 115.339 0.585
202212 0.845 115.116 0.854
202303 0.184 115.116 0.186
202306 -0.049 114.558 -0.050
202309 -0.244 115.339 -0.246
202312 1.234 114.781 1.250
202403 -0.505 115.227 -0.510
202406 0.129 114.781 0.131
202409 0.298 115.785 0.299
202412 1.095 114.893 1.108
202503 -0.112 115.116 -0.113
202506 0.476 114.907 0.482
202509 0.441 115.471 0.444
202512 0.851 115.832 0.854
202603 -0.136 116.303 -0.136

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥1.28 mean?
Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) has a Cyclically Adjusted FCF per Share of ¥1.28 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Guangzhou Kingmed Diagnostics Group Co and its competitors.
Is Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted FCF per Share too high?
Guangzhou Kingmed Diagnostics Group Co's current Cyclically Adjusted FCF per Share is ¥1.28. Overall, Guangzhou Kingmed Diagnostics Group Co has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted FCF per Share compare to TMO and DHR?
Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted FCF per Share of ¥1.28 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted FCF per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Guangzhou Kingmed Diagnostics Group Co and its competitors. Guangzhou Kingmed Diagnostics Group Co's current Cyclically Adjusted FCF per Share is ¥1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Kingmed Diagnostics Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.10, compared to a current price of ¥28.97 — trading 3.1% above its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥1.28. Guangzhou Kingmed Diagnostics Group Co's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Guangzhou Kingmed Diagnostics Group Co (SHSE:603882), the current Cyclically Adjusted FCF per Share is ¥1.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co stock appears to be overvalued. The current stock price of ¥28.97 is trading 3.1% above its estimated GF Value™ of ¥28.10. GuruFocus considers Guangzhou Kingmed Diagnostics Group Co to be Fairly Valued.

Key valuation signals for SHSE:603882:

  • Cyclically Adjusted FCF per Share: ¥1.28
  • GF Value™: ¥28.10 vs. price of ¥28.97 (3.1% above fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the SHSE:603882 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guangzhou Kingmed Diagnostics Group Co Business Description

Address International Biological Island spiral three on the 10th, Guangdong Province, Guangzhou, CHN, 510000
Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2024, KingMed has 50 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.
75GF Score

Get the complete analysis for SHSE:603882

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥28.97
Price
¥28.10
GF Value